(IMVT) Immunovant - Performance -37% in 12m
IMVT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-25.27%
#45 in Peer-Group
Rel. Strength
13.42%
#6645 in Stock-Universe
Total Return 12m
-36.95%
#114 in Peer-Group
Total Return 5y
-30.70%
#46 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 34.03 USD |
| 52 Week Low | 13.31 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 94.34 |
| Buy/Sell Signal +-5 | 0.28 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IMVT (-37%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: IMVT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IMVT
| Total Return (including Dividends) | IMVT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 10.50% | 3.36% | 5.25% |
| 3 Months | 16.26% | 15.73% | 24.13% |
| 12 Months | -36.95% | -7.02% | 14.15% |
| 5 Years | -30.70% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | IMVT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 23.2% | 4.4% | 81% |
| 3 Months | 56% | 78.8% | 96.9% |
| 12 Months | -89.4% | -85.8% | 44.9% |
| 5 Years | 20.1% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th75.50 | 6.91% | 4.99% |
| 3 Month | %th49.00 | 0.45% | -6.34% |
| 12 Month | %th43.00 | -32.19% | -44.77% |
| 5 Years | %th78.50 | -8.57% | -67.29% |
FAQs
Does Immunovant (IMVT) outperform the market?
No,
over the last 12 months IMVT made -36.95%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months IMVT made 16.26%, while XBI made 15.73%.
Performance Comparison IMVT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IMVT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.6% | 5.3% | -36.8% | -51% |
| US NASDAQ 100 | QQQ | 3.8% | 5.2% | -37.5% | -50% |
| German DAX 40 | DAX | 5.7% | 11.9% | -49% | -66% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.7% | 7.3% | -40.3% | -57% |
| Hongkong Hang Seng | HSI | 4% | 4.4% | -56.3% | -76% |
| India NIFTY 50 | INDA | 5.4% | 7% | -37.2% | -36% |
| Brasil Bovespa | EWZ | 1.1% | 1.7% | -61.9% | -47% |
IMVT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5% | 4.6% | -41% | -61% |
| Consumer Discretionary | XLY | 4.1% | 7.3% | -29.2% | -55% |
| Consumer Staples | XLP | 3.3% | 9.9% | -38.5% | -46% |
| Energy | XLE | 3.3% | 3.4% | -32.7% | -37% |
| Financial | XLF | 2.9% | 5.4% | -41.8% | -67% |
| Health Care | XLV | 4.1% | 8.4% | -29.5% | -32% |
| Industrial | XLI | 3.5% | 6.3% | -44.7% | -62% |
| Materials | XLB | 1.3% | 6.2% | -41.4% | -43% |
| Real Estate | XLRE | 3.6% | 9.5% | -36.6% | -50% |
| Technology | XLK | 2.8% | 1.8% | -39.2% | -48% |
| Utilities | XLU | 4.7% | 8.7% | -40.1% | -60% |
| Aerospace & Defense | XAR | 5.7% | 3.4% | -55.4% | -86% |
| Biotech | XBI | 2.6% | 7.1% | -23.6% | -30% |
| Homebuilder | XHB | 1.1% | 3.5% | -29.7% | -42% |
| Retail | XRT | 1% | 5.5% | -32.5% | -48% |
IMVT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.7% | 2.06% | -28.5% | -29% |
| Natural Gas | UNG | 13.1% | 20.3% | -20.1% | -35% |
| Gold | GLD | 3.3% | 11.7% | -57.5% | -76% |
| Silver | SLV | 2.6% | 3.6% | -54.2% | -55% |
| Copper | CPER | 4.5% | 5.9% | -53.9% | -48% |
IMVT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.4% | 9.5% | -33.4% | -35% |
| iShares High Yield Corp. Bond | HYG | 4.8% | 8.9% | -35.7% | -47% |